However, treatment with the ET antagonist darusentan restored normal endothelial function [20], suggesting that endothelial NO, but not endothelium-derived prostanoids, mediates a portion of the relaxation response to ACh and this observation highlights the contribution of ET-1 to endothelial dysfunction. This evidence concerns the gene EDN1 and endothelial dysfunction.